Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000-2018

被引：16
作者：
Ramzan, Sara [1 ]
Timmins, Peter [1 ]
Hasan, Syed Shahzad [1 ]
Babar, Zaheer-Ud-Din [1 ]
机构：
[1] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
来源：
PRIMARY CARE DIABETES | 2019年 / 13卷 / 05期
关键词：
TYPE-2; DIABETES-MELLITUS; EUROPEAN-ASSOCIATION; CARDIOVASCULAR OUTCOMES; CONSENSUS STATEMENT; GLYCEMIC CONTROL; INSULIN THERAPY; DRUG-USE; PATTERNS; HYPERGLYCEMIA; MANAGEMENT;
D O I：
10.1016/j.pcd.2019.05.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle-Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices. (C) 2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：409 / 421
页数：13
相关论文
共 73 条
[11]  
[Anonymous], 2016, BMJ OPEN
[12]  
[Anonymous], INF HEALTHC PROF ROS
[13]  
[Anonymous], COCHRANE HDB SYSTEMA
[14]  
[Anonymous], INDS RAT FARM
[15]  
[Anonymous], 2016, NEWCASTLE OTTAWA SCA
[16]  
[Anonymous], DIABETES PRIMARY CAR
[17]  
[Anonymous], EUR MED AG CLAR OP P
[18]  
[Anonymous], EXPERT REV PHARMACOE
[19]  
[Anonymous], Guideline on Clinical Investigation of Medicinal Products for the Treatment of Sepsis.
[20]  
[Anonymous], MED BALTIMORE
12345678